METACARDIS

portrait of Prof. Karine Clément

Prof. Karine Clément

Scientific Coordinator of METACARDIS, Institut National de la Santé et de la Recherche Médicale (Inserm) and Director of the Institute of Cardiometabolism and Nutrition (ICAN) in Paris, France

Research field

Genomics, Obesity, Nutrition

If you like this
If you want to know more
Research Profile

Who?

Prof. Clément is a scientist and a medical doctor. “I am interested in the biological basis of metabolic diseases such as obesity. I want to know why some patients develop complications and others do not. My ambition is to be able to offer metabolic disease patients a personalised treatment”, says Prof. Clément.

Why?

Prof. Clément: “CMDs such as heart disease, diabetes, and obesity are a major cause of death and disease around the world. It is estimated that they cost the European economy more than €192 billion a year. This will increase in the future because the population is ageing. We need to find better ways to treat CMD patients ”.

What?

Our body is colonised by an immense number of microbes (microscopic organisms such as bacteria). These are referred to as human microbiota. METACARDIS aims to study the role of the gut microbiota in cardiometabolic diseases (CMDs). The project will improve our ability to diagnose CMDs and to predict the risk of complications.

How?

METACARDIS is the first systemic attempt to correlate gut microbiota with CMD stages. With the financial support of the European Commission, 14 partners in 6 countries can collaborate for 5 years. The teams will use state-of-the-art technologies to accelerate the development of novel preventive and therapeutic methods for CMDs.

Studying the gut flora in diabetes, obesity and cardiovascular disease

In the Picture
In the Picture
Image credits

Background image: METACARDIS

Portrait of the project coordinator: METACARDIS

Timeline (in chronological order): METACARDIS